SCHEMBL19251670

SCHEMBL19251670

CC(=O)Nc1cccc(Oc2nc(Nc3ccc(C(=O)N(C)C)c(Cl)c3)nc3ccsc23)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.63
EGFR P00533 9/20 0.53
KDR P35968 2/20 0.53
BTK Q06187 2/20 0.53
ABCB11 O95342 1/20 0.53
ESR1 P03372 1/20 0.53
CHRM2 P08172 1/20 0.53
HTR1A P08908 1/20 0.53
ADRA2A P08913 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
CHRM1 P11229 1/20 0.53
DRD1 P21728 1/20 0.53
TBXA2R P21731 1/20 0.53
SLC6A2 P23975 1/20 0.53
PDE4A P27815 1/20 0.53
ADRA1A P35348 1/20 0.53
OPRM1 P35372 1/20 0.53
DRD3 P35462 1/20 0.53
SLC6A3 Q01959 1/20 0.53
KCNH2 Q12809 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14915305 0.91 EGFR (0.66) RAD52EGFRKDRBTKABCB11
SCHEMBL19253121 0.84 EGFR (0.66) RAD52EGFRKDRBTKABCB11
SCHEMBL19253119 0.84 EGFR (0.56) RAD52EGFRKDRBTKABCB11
SCHEMBL19253387 0.82 EGFR (0.59) RAD52EGFRKDRBTKABCB11
SCHEMBL17996126 0.81 EGFR (0.66) RAD52EGFRKDRBTKABCB11
SCHEMBL19251249 0.80 EGFR (0.57) RAD52EGFRKDRBTKABCB11
SCHEMBL19253114 0.80 EGFR (0.57) RAD52EGFRKDRBTKABCB11
SCHEMBL14915532 0.79 BTK (0.72) RAD52EGFRKDRBTKABCB11
SCHEMBL23365456 0.78 EGFR (0.82) RAD52EGFRKDRBTKABCB11
SCHEMBL19253144 0.78 RAD52 (0.63) RAD52EGFRKDRBTKABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE46511-E1 Fused pyrimidine derivatives for inhibition of tyrosine kinase activity HANMI SCIENCE CO., LTD. (KR) 2017-08-15 US disclosed